Evidence map›Paper›PMID 30071902›Full record

ReviewMolecular neurodegeneration2018

A new hypothesis for Parkinson's disease pathogenesis: GTPase-p38 MAPK signaling and autophagy as convergence points of etiology and genomics.

Julia Obergasteiger, Giulia Frapporti, Peter P Pramstaller, Andrew A Hicks, Mattia Volta

Open access · goldAbstract readReview
In one paragraph

Review in Molecular neurodegeneration, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 103 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Decoding the therapeutic potential mechanism ofFrontiers in pharmacology · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Beneficial Role of Vitexin in Parkinson's Disease.The Malaysian journal of medical sciences : MJMS · 2023
    Review
  18. Article
  19. Zoological research · 2023
    Article
  20. Lysosomal Pathogenesis of Parkinson's Disease: Insights From LRRK2 and GBA1 Rodent Models.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 2 countries.

Julia ObergasteigerInstitute for Biomedicine, Eurac Research - Affiliated Institute of the University of Lübeck, Via Galvani 31, 39100, Bolzano, Italy.
Giulia FrapportiInstitute for Biomedicine, Eurac Research - Affiliated Institute of the University of Lübeck, Via Galvani 31, 39100, Bolzano, Italy.
Peter P PramstallerInstitute for Biomedicine, Eurac Research - Affiliated Institute of the University of Lübeck, Via Galvani 31, 39100, Bolzano, Italy.
Andrew A HicksInstitute for Biomedicine, Eurac Research - Affiliated Institute of the University of Lübeck, Via Galvani 31, 39100, Bolzano, Italy.
Mattia VoltaInstitute for Biomedicine, Eurac Research - Affiliated Institute of the University of Lübeck, Via Galvani 31, 39100, Bolzano, Italy. mattia.volta@eurac.edu.ORCID 0000-0002-0300-6796
Eurac Research · IT

Funding

Deutsche Forschungsgemeinschaft FOR2488 Z2/Z1
6 · The paper itself

Abstract

The combination of genetics and genomics in Parkinson´s disease has recently begun to unveil molecular mechanisms possibly underlying disease onset and progression. In particular, catabolic processes such as autophagy have been increasingly gaining relevance as post-mortem evidence and experimental models suggested a participation in neurodegeneration and alpha-synuclein Lewy body pathology. In addition, familial Parkinson´s disease linked to LRRK2 and alpha-synuclein provided stronger correlation between etiology and alterations in autophagy. More detailed cellular pathways are proposed and genetic risk factors that associate with idiopathic Parkinson´s disease provide further clues in dissecting contributions of single players. Nevertheless, the fine-tuning of these processes remains elusive, as the initial stages of the pathways are not yet clarified.In this review, we collect literature evidence pointing to autophagy as the common, downstream target of Parkinsonian dysfunctions and augment current knowledge on the factors that direct the subsequent steps. Cell and molecular biology evidence indicate that p38 signaling underlies neurodegeneration and autoptic observations suggest a participation in neuropathology. Moreover, alpha-synuclein and LRRK2 also appear involved in the p38 pathway with additional roles in the regulation of GTPase signaling. Small GTPases are critical modulators of p38 activation and thus, their functional interaction with aSyn and LRRK2 could explain much of the detailed mechanics of autophagy in Parkinson´s disease.We propose a novel hypothesis for a more comprehensive working model where autophagy is controlled by upstream pathways, such as GTPase-p38, that have been so far underexplored in this context. In addition, etiological factors (LRRK2, alpha-synuclein) and risk loci might also combine in this common mechanism, providing a powerful experimental setting to dissect the cause of both familial and idiopathic disease.

Indexed as

AutophagyHumansMAP Kinase Signaling SystemParkinson Diseasealpha-synucleinautophagygeneticsGWASLRRK2lysosomeMAPKneuropathologyp38Parkinson´s disease

Identifiers

PMID30071902
PMCPMC6090926
OpenAlexW2885509648

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.